← Evidence map

ArticlePloS one2023

In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.

Rajesh Mondal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36867599